Fig. 2From: Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysisForest plots for the comparison of ORs for OS in all included HCC patients with PVTT who received HR or TACE. Outcomes: a 1-year OS; b 2-year OS; c 3-year OS; d 5-year OS; A random effects model was used in the meta-analyses of the three outcomesBack to article page